A drainage implant or device, also known as a tube shunt, is implanted in the sclera of patients with glaucoma to maintain an artificial drainage pathway and control intraocular pressure. Intraocular pressure is lowered when aqueous humor flows from inside the eye through the tube into the space between the plate that rests on the scleral surface and surrounding fibrous capsule.(1-3)
A drainage implant or device, also known as a tube shunt, is implanted in the sclera of patients with glaucoma to maintain an artificial drainage pathway and control intraocular pressure. Intraocular pressure is lowered when aqueous humor flows from inside the eye through the tube into the space between the plate that rests on the scleral surface and surrounding fibrous capsule.(1-3)
The implantation of a drainage device is used to treat glaucoma that is refractory to medical and standard surgical therapy.(1-3) These are usually cases in which standard drainage procedures have failed or patients have a poor prognosis. These cases involve failed trabeculectomy, buphthalmos and juvenile glaucoma, neovascular glaucoma and glaucoma secondary to uveitis, traumatic glaucoma, cataract with glaucoma, and high-risk primary glaucoma.(1-3)
For certain glaucoma drainage implants, radiographic findings may suggest detection of an orbital foreign body if the ophthalmic history is unknown, as reported by Ceballos and Parrish.(3) In this case report, a patient was denied an MRI examination for fear of dislodging an apparent "metallic foreign body." In fact, the patient had a Baerveldt glaucoma drainage implant, which was mistakenly identified as an orbital metallic object based on its radiographic characteristics (i.e., due to the presence of barium-impregnated silicone.(3)
At least one glaucoma drainage implant, the ExPRESS miniature glaucoma shunt (Optonol, Neve Ilan, Israel) is made from 316L stainless steel.(4,5) However, many glaucoma drainage implants are made from nonmetallic materials and are safe for patients undergoing MRI procedures.(3) Commonly used devices that do not contain metal include the following:
Frank G. Shellock, Ph.D., FACC, FACSM, is an adjunct clinical professor of radiology and medicine at Keck School of Medicine, University of Southern California, and Institute for Magnetic Resonance Safety, Education, and Research.
www.MRIsafety.com
www.IMRSER.org
References
1. Sidoti PA, Baerveldt G. Glaucoma drainage implants. Curr Opin Ophthalmol 1994;5:85-98.
2. Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005;50:48-60.
3. Ceballos EM, Parrish RK. Plain film imaging of Baerveldt glaucoma drainage implants. AJNR 2002;23;935-937.
4. Traverso CE, De Feo F, Messas-Kaplan A, et al. Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification. Br J Ophthalmol 2005;89:425-429.
5. Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleral flap. J Glaucoma 2005;14:98-102.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.